Adapthealth Corp (AHCO)vsNovartis AG ADR (NVS)
AHCO
Adapthealth Corp
$7.87
+0.90%
HEALTHCARE · Cap: $1.00B
NVS
Novartis AG ADR
$160.32
-0.04%
HEALTHCARE · Cap: $303.67B
Smart Verdict
WallStSmart Research — data-driven comparison
Novartis AG ADR generates 1569% more annual revenue ($57.36B vs $3.44B). NVS leads profitability with a 17.5% profit margin vs -11.8%. NVS earns a higher WallStSmart Score of 48/100 (D+).
AHCO
Hold47
out of 100
Grade: D+
NVS
Hold48
out of 100
Grade: D+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+66.4%
Fair Value
$31.37
Current Price
$7.87
$23.50 discount
Margin of Safety
-69.8%
Fair Value
$95.76
Current Price
$160.32
$64.56 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Mega-cap, among the largest globally
Strong operational efficiency at 34.3%
Every $100 of equity generates 27 in profit
Generating 4.8B in free cash flow
Areas to Watch
Smaller company, higher risk/reward
Operating margin of 2.3%
Elevated debt levels
ROE of -33.2% — below average capital efficiency
Premium valuation, high expectations priced in
Trading at 8.1x book value
4.7% revenue growth
Grey zone — moderate risk
Comparative Analysis Report
WallStSmart ResearchBull Case : AHCO
The strongest argument for AHCO centers on Price/Book. Revenue growth of 10.9% demonstrates continued momentum.
Bull Case : NVS
The strongest argument for NVS centers on Market Cap, Operating Margin, Return on Equity. Profitability is solid with margins at 17.5% and operating margin at 34.3%.
Bear Case : AHCO
The primary concerns for AHCO are Market Cap, Operating Margin, Debt/Equity. Debt-to-equity of 1.67 is elevated, increasing financial risk.
Bear Case : NVS
The primary concerns for NVS are P/E Ratio, Price/Book, Revenue Growth.
Key Dynamics to Monitor
AHCO profiles as a turnaround stock while NVS is a value play — different risk/reward profiles.
AHCO carries more volatility with a beta of 1.32 — expect wider price swings.
AHCO is growing revenue faster at 10.9% — sustainability is the question.
NVS generates stronger free cash flow (4.8B), providing more financial flexibility.
Bottom Line
NVS scores higher overall (48/100 vs 47/100), backed by strong 17.5% margins. AHCO offers better value entry with a 66.4% margin of safety. Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Adapthealth Corp
HEALTHCARE · MEDICAL DEVICES · USA
AdaptHealth Corp. The company is headquartered in Plymouth Meeting, Pennsylvania.
Visit Website →Novartis AG ADR
HEALTHCARE · DRUG MANUFACTURERS - GENERAL · USA
Novartis AG researches, develops, manufactures and markets medical devices worldwide. The company is headquartered in Basel, Switzerland.
Visit Website →Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?